Evi S Lianidou

37PUBLICATIONS
129CO-AUTHORS
Molecular targetsCancer geneticsPredictive and prognostic markersTumour immunologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Jun 12, 2026
AXL-mRNA Overexpression in Size-Based Enriched Circulating Tumor Cells as a Potential Biomarker for Anti-AXL Targeted Therapies in Non-Small-Cell Lung Cancer.

|May 27, 2026
ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma-cfDNA of advanced breast cancer patients: A feasibility proof-of-concept study.

|Mar 26, 2026
Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients.

Stefan Werner, Pierre Tennstedt, Randi C Pose

|Feb 18, 2026
Metabolic marker profiling of circulating tumour cells in NSCLC patients treated with osimertinib: focus on MCT1 and MCT4.

Karolina Mangani, Evangelia Pantazaka, Evi Lianidou

|Mar 18, 2025
Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis.

Wolfgang Janni, Thomas W P Friedl, Tracy C Yab

|Feb 13, 2025
Targeting the PD-1/PD-L1 Signaling Pathway for Cancer Therapy: Focus on Biomarkers.

Areti Strati, Christos Adamopoulos, Ioannis Kotsantis

Pageof 7

Frequent Collaborators

12 joint publications

Athina N Markou

11 joint publications

Vassilis Georgoulias

11 joint publications

Vassilis Georgoulias

11 joint publications

Areti Strati